OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period
Danyi Ao, Xuemei He, Jian Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Danyi Ao, Xuemei He, Jian Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
The emerging challenge of FLiRT variants: KP.1.1 and KP.2 in the global pandemic landscape
Prithiv K R Kumar, Jezina Jayan, Rakesh Sharma, et al.
QJM (2024) Vol. 117, Iss. 7, pp. 485-487
Closed Access | Times Cited: 12
Prithiv K R Kumar, Jezina Jayan, Rakesh Sharma, et al.
QJM (2024) Vol. 117, Iss. 7, pp. 485-487
Closed Access | Times Cited: 12
SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines
Xi Li, Ze Mi, Zhenguo Liu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 6
Xi Li, Ze Mi, Zhenguo Liu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 6
Lipid-encapsulated gold nanoparticles: an advanced strategy for attenuating the inflammatory response in SARS-CoV-2 infection
Sanjeevram Dhandapani, Yujeong Ha, Rongbo Wang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Sanjeevram Dhandapani, Yujeong Ha, Rongbo Wang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Role of Artificial Intelligence in Identifying Vital Biomarkers with Greater Precision in Emergency Departments During Emerging Pandemics
Nicolás J. Garrido, Félix González-Martínez, Ana M. Torres, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 722-722
Open Access
Nicolás J. Garrido, Félix González-Martínez, Ana M. Torres, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 722-722
Open Access
Evaluation of the Content Validity of the COVID-19 Symptoms Daily Diary
Jennifer Dine, Yanfen Guan, Mirline Milien, et al.
Patient Related Outcome Measures (2025) Vol. Volume 16, pp. 37-53
Open Access
Jennifer Dine, Yanfen Guan, Mirline Milien, et al.
Patient Related Outcome Measures (2025) Vol. Volume 16, pp. 37-53
Open Access
Mixed lipopeptide-based mucosal vaccine candidate induces cross-variant immunity and protects against SARS-CoV-2 infection in hamsters
Raj S. Patel, Diana Duque, Jegarubee Bavananthasivam, et al.
ImmunoHorizons (2025) Vol. 9, Iss. 2
Open Access
Raj S. Patel, Diana Duque, Jegarubee Bavananthasivam, et al.
ImmunoHorizons (2025) Vol. 9, Iss. 2
Open Access
A20 as a Potential Therapeutic Target for COVID‐19
Yongyao Wu, He Li, Rong Li, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 1
Open Access
Yongyao Wu, He Li, Rong Li, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 1
Open Access
Comprehensive preclinical characterization of IPB29, a pan-coronavirus fusion inhibitor under clinical trials
Yuanmei Zhu, Zhongcai Gao, Xiaoli Feng, et al.
Antiviral Research (2025), pp. 106154-106154
Closed Access
Yuanmei Zhu, Zhongcai Gao, Xiaoli Feng, et al.
Antiviral Research (2025), pp. 106154-106154
Closed Access
A Paper-Based Multiplexed Serological Test to Monitor Immunity against SARS-COV-2 Using Machine Learning
Merve Eryılmaz, Artem Goncharov, Gyeo‐Re Han, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16819-16831
Open Access | Times Cited: 4
Merve Eryılmaz, Artem Goncharov, Gyeo‐Re Han, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16819-16831
Open Access | Times Cited: 4
Extracellular Vesicle microRNA: A Promising Biomarker and Therapeutic Target for Respiratory Diseases
Jiaxi Lv, Xian‐Zhi Xiong
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9147-9147
Open Access | Times Cited: 4
Jiaxi Lv, Xian‐Zhi Xiong
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9147-9147
Open Access | Times Cited: 4
Bile acids and coronavirus disease 2019
Xiaoru Huang, Xuening Liu, Zijian Li
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1939-1950
Open Access | Times Cited: 3
Xiaoru Huang, Xuening Liu, Zijian Li
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1939-1950
Open Access | Times Cited: 3
Large-scale Deep Learning Identifies the Antiviral Potential of PKI-179 and MTI-31 Against Coronaviruses
Demi van der Horst, Madalina E. Carter-Timofte, Adeline Danneels, et al.
Antiviral Research (2024) Vol. 231, pp. 106012-106012
Open Access | Times Cited: 3
Demi van der Horst, Madalina E. Carter-Timofte, Adeline Danneels, et al.
Antiviral Research (2024) Vol. 231, pp. 106012-106012
Open Access | Times Cited: 3
Identifying COVID‐19 subtypes by single‐sample gene set enrichemnt analysis and providing guidance for sensitive drug selection
Nan Xiong, Qiangming Sun
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 2
Nan Xiong, Qiangming Sun
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 2
Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent
Falko Tesch, Franz Ehm, Friedrich Loser, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Falko Tesch, Franz Ehm, Friedrich Loser, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Clinical and prognostic implications of hyaluronic acid in patients with COVID-19 reinfection and first infection
Yanyan Li, Ming Han, Xin Li
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Yanyan Li, Ming Han, Xin Li
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
The consequences of SARS-CoV-2 within-host persistence
Alex Sigal, Richard A. Neher, Richard Lessells
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
Alex Sigal, Richard A. Neher, Richard Lessells
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent
Falko Tesch, Franz Ehm, Friedrich Loser, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Falko Tesch, Franz Ehm, Friedrich Loser, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Immunogenicity and safety of an Omicron XBB.1.16 adapted vaccine for COVID-19: Interim results from a randomized, controlled, non-inferiority clinical trial
María Jesús López Fernandez, Silvia Narejos, Antoni Castro-Guardiola, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
María Jesús López Fernandez, Silvia Narejos, Antoni Castro-Guardiola, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Revealing SARS-CoV-2 Mpro Mutation Cold and Hot Spots: Dynamic Residue Network Analysis Meets Machine Learning
Victor Barozi, Shrestha Chakraborty, S. Govender, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3800-3816
Open Access | Times Cited: 1
Victor Barozi, Shrestha Chakraborty, S. Govender, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3800-3816
Open Access | Times Cited: 1
A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus
Ji Hyun Lee, Ji Woong Kim, H Lee, et al.
Virus Research (2024) Vol. 345, pp. 199383-199383
Open Access
Ji Hyun Lee, Ji Woong Kim, H Lee, et al.
Virus Research (2024) Vol. 345, pp. 199383-199383
Open Access
Effectiveness of Monovalent Vaccines in Preventing Omicron-associated Death and Severe Disease Among Hospitalized Patients in China
Ming-Jin Liu, Wei Zhang, Yang Yang, et al.
SSRN Electronic Journal (2024)
Closed Access
Ming-Jin Liu, Wei Zhang, Yang Yang, et al.
SSRN Electronic Journal (2024)
Closed Access
Development of a high-performance liquid chromatography using rhodamine B hydrazide as the derivatization reagent for determination of β propiolactone residues in inactivated COVID-19 vaccines
Seyedeh Zohreh Mirjalili, Fatemeh Chavoshi, Mohsen Amini, et al.
Journal of Chromatography B (2024) Vol. 1244, pp. 124241-124241
Closed Access
Seyedeh Zohreh Mirjalili, Fatemeh Chavoshi, Mohsen Amini, et al.
Journal of Chromatography B (2024) Vol. 1244, pp. 124241-124241
Closed Access
Potential SARS-CoV-2 Mpro steroid inhibitors from Aphanamixis polystachya (Wall.) R. N. Parker
Juan Ren, Shi-Rui Fan, Jie‐Yun Cai, et al.
Fitoterapia (2024) Vol. 177, pp. 106134-106134
Closed Access
Juan Ren, Shi-Rui Fan, Jie‐Yun Cai, et al.
Fitoterapia (2024) Vol. 177, pp. 106134-106134
Closed Access
Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results
María Jesús López Fernández, Silvia Narejos, Antoni Castro-Guardiola, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 840-840
Open Access
María Jesús López Fernández, Silvia Narejos, Antoni Castro-Guardiola, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 840-840
Open Access
COVID-19 Vaccination and Transient Increase in CD4/CD8 Cell Counts in People with HIV: Evidence from China
Yanyan Li, Yingying Lin, Yunyun Yi, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1365-1365
Open Access
Yanyan Li, Yingying Lin, Yunyun Yi, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1365-1365
Open Access
